Indication: solid tumor

Description:

1. It is used for the treatment of various solid tumors such as non-small cell lung cancer.

2. Trivalent bispecific antibody targeting VEGF / Ang2. By inhibiting tumor angiogenesis and vascularization, enhancing tumor microenvironment and realizing tumor treatment; It can be a potential candidate for use in combination with PD-1 inhibitors; The fusion of HSA nano antibody can prolong the half-life in vivo.

3. Foreign similar drugs are in clinical phase I / II.